|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 294 IDR | 0.00% |
|
+2.08% | -15.52% |
| 04-29 | PT Suparma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-01 | PT Suparma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Suparma Tbk reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was IDR 2,357,992.61 million compared to IDR 1,924,882.71 million a year ago. Net income was IDR 246,443.96 million compared to IDR 188,172.17 million a year ago.
Basic earnings per share from continuing operations was IDR 85 compared to IDR 70.7965 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.52% | 57.72M | |
| +29.99% | 6.23B | |
| +38.53% | 2.65B | |
| +13.70% | 1.59B | |
| -6.13% | 1.56B | |
| -16.81% | 1.22B | |
| +23.89% | 1.07B | |
| -4.35% | 1.03B | |
| -24.14% | 830M | |
| -10.68% | 821M |
PT SUPARMA TBK 